GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $202,000 | -16.9% | 2,074 | +4.5% | 0.01% | -22.2% |
| Q2 2020 | $243,000 | -11.6% | 1,984 | -24.5% | 0.01% | -18.2% |
| Q4 2019 | $275,000 | -23.6% | 2,628 | -16.0% | 0.01% | -31.2% |
| Q3 2019 | $360,000 | +2.0% | 3,127 | +52.9% | 0.02% | +6.7% |
| Q2 2019 | $353,000 | +8.6% | 2,045 | +6.1% | 0.02% | 0.0% |
| Q1 2019 | $325,000 | -14.5% | 1,928 | -12.2% | 0.02% | -11.8% |
| Q3 2018 | $380,000 | +37.2% | 2,197 | +10.8% | 0.02% | +41.7% |
| Q2 2018 | $277,000 | +158.9% | 1,982 | +109.1% | 0.01% | +140.0% |
| Q1 2018 | $107,000 | +167.5% | 948 | +216.0% | 0.01% | +150.0% |
| Q4 2017 | $40,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |